NCT/Study#
NCT04577807 /
LUMINOS-102
PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma
DISEASE GROUP:
Skin and Soft Tissue
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
